{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T10:40:06Z","timestamp":1780569606261,"version":"3.54.1"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T00:00:00Z","timestamp":1567641600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0221948","type":"journal-article","created":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T17:23:50Z","timestamp":1567704230000},"page":"e0221948","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["The risk of bone fracture after long-term risperidone exposure is not increased compared to other atypical antipsychotics: A retrospective cohort study"],"prefix":"10.1371","volume":"14","author":[{"given":"Shih-Pei","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Yi","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Chi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Miin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank Huang-Chih","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,9,5]]},"reference":[{"issue":"9","key":"pone.0221948.ref001","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0149-2918(00)80086-7","article-title":"The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia","volume":"22","author":"SR David","year":"2000","journal-title":"Clin Ther"},{"issue":"1","key":"pone.0221948.ref002","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1592\/phco.29.1.64","article-title":"Antipsychotic-induced hyperprolactinemia","volume":"29","author":"JR Bostwick","year":"2009","journal-title":"Pharmacotherapy"},{"issue":"2 Suppl","key":"pone.0221948.ref003","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/0269881107088439","article-title":"Antipsychotic-induced hyperprolactinaemia, hypogonadism and osteoporosis in the treatment of schizophrenia","volume":"22","author":"V O'Keane","year":"2008","journal-title":"J Psychopharmacol"},{"key":"pone.0221948.ref004","first-page":"167138","article-title":"Osteoporosis associated with antipsychotic treatment in schizophrenia","volume":"2013","author":"H Wu","year":"2013","journal-title":"Int J Endocrinol"},{"issue":"Suppl 1","key":"pone.0221948.ref005","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0306-4530(02)00112-9","article-title":"Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects","volume":"28","author":"U Halbreich","year":"2003","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"pone.0221948.ref006","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00004850-200401000-00006","article-title":"Schizophrenia and osteoporosis","volume":"19","author":"M Lean","year":"2004","journal-title":"Int Clin Psychopharmacol"},{"issue":"9","key":"pone.0221948.ref007","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/PSY.0b013e3181f7abd3","article-title":"Skeletal status in psychotic disorders: a population-based study","volume":"72","author":"K Partti","year":"2010","journal-title":"Psychosom Med"},{"issue":"6","key":"pone.0221948.ref008","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1517\/14740338.2016.1167873","article-title":"Relationship between antipsychotic medication, serum prolactin levels and osteoporosis\/osteoporotic fractures in patients with schizophrenia: a critical literature review","volume":"15","author":"M De Hert","year":"2016","journal-title":"Expert Opin Drug Saf"},{"key":"pone.0221948.ref009","unstructured":"Ernst D. New Warning Added to Antipsychotic Drug Labeling: Monthly Prescribing Reference; [updated February 27, 2017; cited 2017 May 3]. http:\/\/www.empr.com\/safety-alerts-and-recalls\/antipsychotic-medication-warning-somnolence-hyoptension\/article\/640400\/."},{"key":"pone.0221948.ref010","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1192\/bjp.bp.106.023671","article-title":"Risk of hip fracture in patients with a history of schizophrenia","volume":"190","author":"L Howard","year":"2007","journal-title":"Br J Psychiatry"},{"issue":"6","key":"pone.0221948.ref011","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.bone.2005.07.005","article-title":"Risk of hip\/femur fractures in patients using antipsychotics","volume":"37","author":"GW Hugenholtz","year":"2005","journal-title":"Bone"},{"issue":"8","key":"pone.0221948.ref012","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.euroneuro.2013.04.002","article-title":"Schizophrenia, antipsychotics and risk of hip fracture: a population-based analysis","volume":"23","author":"HJ Sorensen","year":"2013","journal-title":"Eur Neuropsychopharmacol"},{"issue":"6","key":"pone.0221948.ref013","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00198-005-0065-y","article-title":"Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture","volume":"17","author":"P Vestergaard","year":"2006","journal-title":"Osteoporos Int"},{"issue":"4","key":"pone.0221948.ref014","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/JCP.0b013e31817d5943","article-title":"Fracture risk from psychotropic medications: a population-based analysis","volume":"28","author":"JM Bolton","year":"2008","journal-title":"J Clin Psychopharmacol"},{"issue":"7\u20138","key":"pone.0221948.ref015","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1345\/aph.1Q589","article-title":"Psychotropic-related hip fractures: meta-analysis of first-generation and second-generation antidepressant and antipsychotic drugs","volume":"46","author":"LH Oderda","year":"2012","journal-title":"Ann Pharmacother"},{"issue":"6","key":"pone.0221948.ref016","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1176\/appi.ajp.2013.13050650","article-title":"Antipsychotic treatment in breast cancer patients","volume":"171","author":"T Rahman","year":"2014","journal-title":"Am J Psychiatry"},{"issue":"2 Suppl","key":"pone.0221948.ref017","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/0269881107088435","article-title":"A review of the association between antipsychotic use and hyperprolactinaemia","volume":"22","author":"C Bushe","year":"2008","journal-title":"J Psychopharmacol"},{"issue":"4","key":"pone.0221948.ref018","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/YIC.0000000000000221","article-title":"Antipsychotic drug exposure and risk of fracture: a systematic review and meta-analysis of observational studies","volume":"33","author":"D Papola","year":"2018","journal-title":"Int Clin Psychopharmacol"},{"issue":"6","key":"pone.0221948.ref019","doi-asserted-by":"crossref","first-page":"e0129366","DOI":"10.1371\/journal.pone.0129366","article-title":"Hypnotics and the Occurrence of Bone Fractures in Hospitalized Dementia Patients: A Matched Case-Control Study Using a National Inpatient Database","volume":"10","author":"H Tamiya","year":"2015","journal-title":"PLoS One"},{"issue":"9","key":"pone.0221948.ref020","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.4088\/JCP.14m09098","article-title":"Antipsychotic treatment and the risk of hip fracture in subjects with schizophrenia: a 10-year population-based case-control study","volume":"76","author":"CS Wu","year":"2015","journal-title":"J Clin Psychiatry"},{"issue":"9","key":"pone.0221948.ref021","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/oxfordjournals.aje.a009714","article-title":"Cognitive impairment, drug use, and the risk of hip fracture in persons over 75 years old: a community-based prospective study","volume":"148","author":"Z Guo","year":"1998","journal-title":"Am J Epidemiol"},{"issue":"4","key":"pone.0221948.ref022","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00001648-199807000-00012","article-title":"Risk factors for fractures in the elderly","volume":"9","author":"H Jacqmin-Gadda","year":"1998","journal-title":"Epidemiology"},{"key":"pone.0221948.ref023","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/1471-2458-10-396","article-title":"Psychotropic drugs and the risk of fractures in old age: a prospective population-based study","volume":"10","author":"J Nurminen","year":"2010","journal-title":"BMC Public Health"},{"key":"pone.0221948.ref024","unstructured":"National Health Insurance Research Database. Taiwan. http:\/\/nhird.nhri.org.tw\/en\/index.htm Accessed 01 May 2013."},{"issue":"4","key":"pone.0221948.ref025","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jpsychires.2012.12.007","article-title":"The incidence and all-cause mortality of pneumonia in patients with schizophrenia: a nine-year follow-up study","volume":"47","author":"FH Chou","year":"2013","journal-title":"J Psychiatr Res"},{"issue":"2\u20133","key":"pone.0221948.ref026","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.schres.2014.09.032","article-title":"The risks of major osteoporotic fractures in patients with schizophrenia: a population-based 10-year follow-up study","volume":"159","author":"KY Tsai","year":"2014","journal-title":"Schizophr Res"},{"key":"pone.0221948.ref027","first-page":"1","article-title":"Higher incidence of hip fracture in newly diagnosed schizophrenic patients in Taiwan","volume":"8","author":"SW Lai","year":"2013","journal-title":"Libyan J Med"},{"issue":"12","key":"pone.0221948.ref028","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s10654-009-9411-2","article-title":"Variable selection: current practice in epidemiological studies","volume":"24","author":"S Walter","year":"2009","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"pone.0221948.ref029","doi-asserted-by":"crossref","first-page":"199","DOI":"10.11613\/BM.2014.022","article-title":"Observational and interventional study design types; an overview","volume":"24","author":"MS Thiese","year":"2014","journal-title":"Biochem Med (Zagreb)"},{"issue":"2","key":"pone.0221948.ref030","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/jgs.15219","article-title":"Falls in Cognitively Impaired Older Adults: Implications for Risk Assessment And Prevention","volume":"66","author":"M Montero-Odasso","year":"2018","journal-title":"J Am Geriatr Soc"},{"key":"pone.0221948.ref031","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.schres.2016.10.035","article-title":"Risk of breast cancer in risperidone users: A nationwide cohort study","volume":"182","author":"J Reutfors","year":"2017","journal-title":"Schizophr Res"},{"issue":"3","key":"pone.0221948.ref032","doi-asserted-by":"crossref","first-page":"385","DOI":"10.4088\/JCP.v69n0307","article-title":"Antipsychotic-induced hyperprolactinemia inhibits the hypothalamo-pituitary-gonadal axis and reduces bone mineral density in male patients with schizophrenia","volume":"69","author":"T Kishimoto","year":"2008","journal-title":"J Clin Psychiatry"},{"issue":"9","key":"pone.0221948.ref033","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1176\/appi.ajp.160.9.1618","article-title":"Effects of elevated serum prolactin on bone mineral density and bone metabolism in female patients with schizophrenia: a prospective study","volume":"160","author":"G Abraham","year":"2003","journal-title":"Am J Psychiatry"},{"issue":"1\u20133","key":"pone.0221948.ref034","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.schres.2014.05.009","article-title":"Second-generation antipsychotics and bone turnover in schizophrenia","volume":"157","author":"K Okita","year":"2014","journal-title":"Schizophr Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0221948","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:17:34Z","timestamp":1588965454000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0221948"}},"subtitle":[],"editor":[{"given":"Kenji","family":"Hashimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,9,5]]},"references-count":34,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,9,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0221948","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,5]]}}}